**UNITED        STATES**

**SECURITIES        AND EXCHANGE COMMISSION**

**WASHINGTON,        D.C. 20549**

**Form        10-QSB**

|    |                                                                                                                        |
|---------|-----------------------------------------------------------------------------------------------------------------------------|
| x  | QUARTERLY REPORT PURSUANT TO SECTION                13 OR                15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |
|    | For                  the quarterly period ended **September                  30, 2005**                                |
|    |                                                                                                                        |
| o  | TRANSITION REPORT UNDER SECTION 13                OR 15(d)                OF THE SECURITIES EXCHANGE ACT OF 1934       |
|    | For                  the transition period from ____________ to                  ____________                          |

| Commission                    file number **0-13092**                                                                                                                         |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                               |
| **SPECTRASCIENCE,                    Inc.**                                                                                                                                   |
| (a                    Development Stage Enterprise)(Exact                    name of small business issueras                    specified in its                    charter)  |

| **Minnesota**                                      |   | **41-1448837**                                           |
|----------------------------------------------------|--------|----------------------------------------------------------|
| (State                  or other jurisdiction      |   | (I.R.S.                  Employer Identification Number) |
| of                  incorporation or organization) |   |                                                     |

| **11568                  Sorrento Valley Rd., Suite 11**    |
|-------------------------------------------------------------|
| **San                  Diego, California 92121**            |
| (Address                    of principal executive offices) |
| **(858)                  847-0200**                    |
| (Issuer's                  telephone number)                |

**APPLICABLE        ONLY TO ISSUERS INVOLVED IN **
**BANKRUPTCY**

**PROCEEDINGS        DURING THE **
**PRECEDING        FIVE YEARS**

----

----

**SpectraScience,        Inc.**

**Index**

|                                                                                                          | **Page****No.**  |
|---------------------------------------------------------------------------------------------------------------|-----------------------|
|                                                                                                          |                  |
| PART                    I FINANCIAL INFORMATION:                                                              | 4                     |
|                                                                                                          |                  |
| Item                    1. Financial Statements (Unaudited)                                                   | 4                     |
|                                                                                                          |                  |
| Item                    2. Management’s Discussion and Analysis or Plan of                    Operation | 10                    |
|                                                                                                          |                  |
| Item                    3. Controls and Procedures                                                            | 13                    |
|                                                                                                          |                  |
| PART                    II OTHER INFORMATION                                                                  | 13                    |
|                                                                                                          |                  |
| Item                    1. Legal Proceedings                                                                  | 13                    |
|                                                                                                          |                  |
| Item                    2. Unregistered Sales of Securities and Use of Proceeds                               | 13                    |
|                                                                                                          |                  |
| Item                    3. Defaults Upon Senior Securities                                                    | 13                    |
|                                                                                                          |                  |
| Item                    4. Submission of Matters to a Vote of Security Holders                                | 13                    |
|                                                                                                          |                  |
| Item                    5. Other Information                                                                  | 14                    |
|                                                                                                          |                  |
| Item                    6. Exhibits                                                                           | 14                    |
|                                                                                                          |                  |
| SIGNATURES                                                                                                    | 15                    |

----

**PART        I**
**FINANCIAL        INFORMATION**
**:**

**Item        1.**
**Financial        Statements (Unaudited)**

**SpectraScience,        Inc.**

**CONDENSED        BALANCE SHEETS**

|                                                                                                                                                                                             |   |                                                             |       |                                                            |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------------------------------------------------------|------------|-----------------------------------------------------------------|--------|
|                                                                                                                                                                                             |   | **September                                  30,****2005**  |       | **December                                  31,****2004**  |   |
|                                                                                                                                                                                             |   | (Unaudited)                                                 |       | (Audited)                                                  |   |
|                                                                                                                                                                                             |   |                                                             |       |                                                            |   |
| ASSETS                                                                                                                                                                                           |   |                                                             |       |                                                       |   |
| Current                                  assets:                                                                                                                                                 |   |                                                             |       |                                                       |   |
| Cash                                  and cash equivalents                                                                                                                                       |   | $                                                                | 617,503    |                                                            | $      | 1,132,505 |   |
| Inventories                                                                                                                                                                                      |   |                                                             | 146,619    |                                                            |   | 149,169 |   |
| Prepaid                                  expenses and other current assets                                                                                                                       |   |                                                             | 40,140     |                                                            |   | 54,400 |   |
| Total                                  current assets                                                                                                                                            |   |                                                             | 804,262    |                                                            |   | 1,336,074 |   |
| Fixed                                  assets, net                                                                                                                                               |   |                                                             | 8,796      |                                                            |   | 15,992 |   |
| Patents,                                  net                                                                                                                                                    |   |                                                             | 267,456    |                                                            |   | 281,949 |   |
| TOTAL                                  ASSETS                                                                                                                                               |   | $                                                                | 1,080,514  |                                                            | $      | 1,634,015 |   |
| LIABILITIES                                  AND STOCKHOLDERS’ EQUITY                                                                                                                      |   |                                                             |       |                                                            |   |   |   |
| Current                                  liabilities:                                                                                                                                            |   |                                                             |       |                                                            |   |   |   |
| Accounts                                  payable                                                                                                                                                |   | $                                                                | 270        |                                                            | $      | 12,215 |   |
| Accrued                                  compensation and taxes                                                                                                                                  |   |                                                             | 11,494     |                                                            |   | 7,684 |   |
| Total                                  liabilities                                                                                                                                               |   |                                                             | 11,764     |                                                            |   | 19,899 |   |
| STOCKHOLDERS’                                  EQUITY                                                                                                                                      |   |                                                             |       |                                                            |   |   |   |
| Undesignated                                  capital stock, undesignated par value, 25,000,000                                  shares authorized, none                                  issued |   |                                                             |       |                                                            |   |   |   |
| Common                                  stock, $.01 par value:                                                                                                                                   |   |                                                             |       |                                                            |   |   |   |
| Authorized--100,000,000                                  shares                                                                                                                                  |   |                                                             |       |                                                            |   |   |   |
| Issued                                  and outstanding--37,550,762 shares                                                                                                                       |   |                                                             | 375,508    |                                                            |   | 375,508 |   |
| Additional                                  paid-in capital                                                                                                                                      |   |                                                             | 1,796,543  |                                                            |   | 1,780,122 |   |
| Deferred                                  compensation                                                                                                                                           |   |                                                             | (67,918    | )                                                               |   | (163,823 | ) |
| Deficit                                  accumulated during the development stage                                                                                                                |   |                                                             | (1,035,383 | )                                                               |   | (377,691 | ) |
| TOTAL                                  STOCKHOLDERS’ EQUITY                                                                                                                                |   |                                                             | 1,068,750  |                                                            |   | 1,614,116 |   |
| TOTAL                                  LIABILITIES AND STOCKHOLDERS’                                  EQUITY                                                                               |   | $                                                                | 1,080,514  |                                                            | $      | 1,634,015 |   |
|                                                                                                                                                                                             |   |                                                             |       |                                                            |   |   |   |

*See        accompanying notes to unaudited condensed financial        statements.*

----

**SpectraScience,        Inc.**

**CONDENSED        STATEMENTS OF OPERATIONS**

**(Unaudited)**

|                                                             |   |                                                       |       |                                                  |   |                                                       |   |                                                       |       |                                                   |   |                                                       |   |                                                                                                              |      |
|------------------------------------------------------------------|--------|------------------------------------------------------------|------------|-------------------------------------------------------|--------|------------------------------------------------------------|--------|------------------------------------------------------------|------------|--------------------------------------------------------|--------|------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------|-----------|
|                                                             |   | 3                    Months Ended September 30, 2005  |       | 1                    Month Ended August 1, 2004  |   | 2                    Months Ended September 30, 2004  |   | 9                    Months Ended September 30, 2005  |       | 7                    Months Ended August 1, 2004  |   | 2                    Months Ended September 30, 2004  |   | August                    2, 2004 (Inception of Successor Company) to September 30,                    2005  |      |
|                                                             |   |                                                       |       |                                                  |   |                                                       |   |                                                       |       |                                                   |   |                                                       |   |                                                                                                              |      |
| Gross                    revenue                                 |   | $                                                          | —    |                                                  | $      | —                                                    |   | $                                                          | —    |                                                   | $      | —                                                    |   | $                                                                                                                 | —   |   | $ | — |   | $ | — |   |
|                                                             |   |                                                       |       |                                                  |   |                                                       |   |                                                       |       |                                                   |   |                                                       |   |                                                                                                              |      |   |   |   |   |   |   |   |
| Operating                    expenses:                           |   |                                                       |       |                                                  |   |                                                       |   |                                                       |       |                                                   |   |                                                       |   |                                                                                                              |      |   |   |   |   |   |   |   |
| Research                    and development                      |   |                                                       | 7,320      |                                                  |   | —                                                    |   |                                                       | —    |                                                   |   | 26,177                                                     |   |                                                                                                              | —   |   |   | — |   |   | 26,177 |   |
| General                    and administrative                    |   |                                                       | 148,186    |                                                  |   | 34,504                                                     |   |                                                       | 218,689    |                                                   |   | 649,138                                                    |   |                                                                                                              | 105,960   |   |   | 218,689 |   |   | 1,038,025 |   |
| Total                    operating expenses                      |   |                                                       | 155,506    |                                                  |   | 34,504                                                     |   |                                                       | 218,689    |                                                   |   | 675,315                                                    |   |                                                                                                              | 105,960   |   |   | 218,689 |   |   | 1,064,202 |   |
|                                                             |   |                                                       |       |                                                  |   |                                                       |   |                                                       |       |                                                   |   |                                                       |   |                                                                                                              |      |   |   |   |   |   |   |   |
| Operating                    loss                                |   |                                                       | (155,506   | )                                                     |   | (34,504                                                    | )      |                                                       | (218,689   | )                                                      |   | (675,315                                                   | )      |                                                                                                              | (105,960  | ) |   | (218,689 | ) |   | (1,064,202 | ) |
| Other                    income (expense), net                   |   |                                                       | 6,074      |                                                  |   | (3,448                                                     | )      |                                                       | 3,186      |                                                   |   | 17,623                                                     |   |                                                                                                              | (24,822   | ) |   | 3,186 |   |   | 28,819 |   |
|                                                             |   |                                                       |       |                                                  |   |                                                       |   |                                                       |       |                                                   |   |                                                       |   |                                                                                                              |      |   |   |   |   |   |   |   |
| Loss                    before reorganization items              |   |                                                       | (149,432   | )                                                     |   | (37,952                                                    | )      |                                                       | (215,503   | )                                                      |   | (657,692                                                   | )      |                                                                                                              | (130,782  | ) |   | (215,503 | ) |   | (1,035,383 | ) |
| Gain                    on debt discharge                        |   |                                                       |       |                                                  |   | 525,380                                                    |   |                                                       |       |                                                   |   |                                                       |   |                                                                                                              | 525,380   |   |   |   |   |   |   |   |
|                                                             |   |                                                       |       |                                                  |   |                                                       |   |                                                       |       |                                                   |   |                                                       |   |                                                                                                              |      |   |   |   |   |   |   |   |
| Net                    income (loss)                             |   | $                                                          | (149,432   | )                                                     | $      | 487,428                                                    |   | $                                                          | (215,503   | )                                                      | $      | (657,692                                                   | )      | $                                                                                                                 | 394,598   |   | $ | (215,503 | ) | $ | (1,035,383 | ) |
| Basic                    and diluted net income (loss) per share |   | $                                                          | (0.00      | )                                                     | $      | 0.02                                                       |   | $                                                          | (0.01      | )                                                      | $      | (0.02                                                      | )      | $                                                                                                                 | 0.04      |   | $ | (0.01 | ) |   |   |   |
| Weighted                    average common shares outstanding    |   |                                                       | 37,550,762 |                                                  |   | 23,739,787                                                 |   |                                                       | 37,509,095 |                                                   |   | 37,550,762                                                 |   |                                                                                                              | 9,733,357 |   |   | 37,509,095 |   |   |   |   |
|                                                             |   |                                                       |       |                                                  |   |                                                       |   |                                                       |       |                                                   |   |                                                       |   |                                                                                                              |      |   |   |   |   |   |   |   |

*See        accompanying notes to unaudited condensed financial        statements.*

----

**SpectraScience,        Inc.**

**CONDENSED        STATEMENTS OF CASH FLOWS**

**(Unaudited**
**)**

|                                                                                                                  |   |                                                                              |      |                                                                          |   |                                                                                 |   |                                                                                                                        |      |
|-----------------------------------------------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------|-----------|-------------------------------------------------------------------------------|--------|--------------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------------------------------|-----------|
|                                                                                                                  |   | **9                    Months****Ended****September                    30, 2005** |      | **7                    Months****Ended****August                    1, 2004** |   | **2                    Months****Ended****September                    30,****2004** |   | **August                    2, 2004 (Inception of Successor****Company)                    to September 30,****2005**  |      |
|                                                                                                                  |   |                                                                              |      |                                                                          |   |                                                                                 |   |                                                                                                                        |      |
| OPERATING                    ACTIVITIES:                                                                              |   |                                                                              |      |                                                                          |   |                                                                                 |   |                                                                                                                        |      |
| Net                    income (loss)                                                                                  |   | $                                                                                 | (657,692  | )                                                                             | $      | 394,598                                                                              |   | $                                                                                                                           | (215,503  | ) | $ | (1,035,383 | ) |
| Adjustment                    to reconcile net income (loss) to                    cash used in operating activities: |   |                                                                              |      |                                                                          |   |                                                                                 |   |                                                                                                                        |      |   |   |   |   |
| Depreciation                    and amortization                                                                      |   |                                                                              | 21,689    |                                                                          |   |                                                                                      |   |                                                                                                                        | 4,021     |   |   | 32,939 |   |
| Gain                    on discharge of debt                                                                          |   |                                                                              |      |                                                                          |   | (525,380                                                                             | )      |                                                                                                                        |      |   |   |   |   |
| Amortization                    of deferred compensation                                                              |   |                                                                              | 112,326   |                                                                          |   | 758                                                                                  |   |                                                                                                                        | 77,609    |   |   |  247,777 |   |
| Gain                    on disposal of fixed assets                                                                   |   |                                                                              |           |                                                                          |   |                                                                                 |   |                                                                                                                        |      |   |   | (4,189 | ) |
| Writeoff                    of obsolete inventories                                                                   |   |                                                                              | 2,754     |                                                                          |   |                                                                                 |   |                                                                                                                        |      |   |   | 2,754 |   |
| Changes                    in operating assets and liabilities:                                                       |   |                                                                              |      |                                                                          |   |                                                                                 |   |                                                                                                                        |      |   |   |   |   |
| Inventories                                                                                                           |   |                                                                              | (204      | )                                                                             |   |                                                                                 |   |                                                                                                                        |      |   |   | (204 | ) |
| Prepaid                    expenses and other current assets                                                          |   |                                                                              | 14,260    |                                                                          |   | (23,750                                                                              | )      |                                                                                                                        | (5,913    | ) |   | (16,390 | ) |
| Accounts                    payable                                                                                   |   |                                                                              | (11,945   | )                                                                             |   | 53,819                                                                               |   |                                                                                                                        | (25,998   | ) |   | (59,432 | ) |
| Accrued                    compensation and taxes                                                                     |   |                                                                              | 3,810     |                                                                          |   | 26,944                                                                               |   |                                                                                                                        | (32,092   | ) |   | (20,599 | ) |
| Net                    cash used in operating activities                                                              |   |                                                                              | (515,002  | )                                                                             |   | (73,011                                                                              | )      |                                                                                                                        | (197,876  | ) |   | (852,727 | ) |
| INVESTING                    ACTIVITIES- proceeds from thesale                    of fixed assets                     |   |                                                                              |      |                                                                          |   |                                                                                 |   |                                                                                                                        | 1,000     |   |   | 8,240 |   |
| Cash                    flows from financing activities:                                                              |   |                                                                              |      |                                                                          |   |                                                                                 |   |                                                                                                                        |      |   |   |   |   |
| Proceeds                    from exchange of common stock                                                             |   |                                                                              |      |                                                                          |   | 886,116                                                                              |   |                                                                                                                        |      |   |   |   |   |
| Proceeds                    from issuance of common stock in reorganization                                           |   |                                                                              |      |                                                                          |   | 50,000                                                                               |   |                                                                                                                        |      |   |   |   |   |
| Proceeds                    from the issuance of common stock                                                         |   |                                                                              |      |                                                                          |   | 505,400                                                                              |   |                                                                                                                        | 20,000    |   |   | 20,000 |   |
| Net                    cash provided by financing activities                                                          |   |                                                                              |      |                                                                          |   | 1,441,516                                                                            |   |                                                                                                                        | 20,000    |   |   | 20,000 |   |
|                                                                                                                  |   |                                                                              |      |                                                                          |   |                                                                                 |   |                                                                                                                        |      |   |   |   |   |
| Net                    increase (decrease) in cash and cash equivalents                                               |   |                                                                              | (515,002  | )                                                                             |   | 1,368,505                                                                            |   |                                                                                                                        | (176,876  | ) |   | (824,487 | ) |
| CASH                    AND CASH EQUIVALENTS ATBEGINNING                    OF PERIOD                                 |   |                                                                              | 1,132,505 |                                                                          |   | 73,487                                                                               |   |                                                                                                                        | 1,441,990 |   |   | 1,441,990 |   |
| CASH                    AND CASH EQUIVALENTS ATEND                    OF PERIOD                                       |   | $                                                                                 | 617,503   |                                                                          | $      | 1,441,992                                                                            |   | $                                                                                                                           | 1,265,114 |   | $ | 617,503 |   |
|                                                                                                                  |   |                                                                              |      |                                                                          |   |                                                                                 |   |                                                                                                                        |      |   |   |   |   |

*See        accompanying notes to unaudited condensed financial        statements.*

----

**SpectraScience,        Inc.**

**Notes        to Unaudited Condensed Financial Statements**

**September        30, 2005**

| **1.  ** | **Nature                  of Business and Basis of                  Presentation** |
|--------------------|------------------------------------------------------------------------------------|

**Description        of Business**

**Basis        of Presentation**

**Liquidity        and Development Stage Enterprise**

----

| **2.  ** | **Summary                  of Significant Accounting                  Policies** |
|--------------------|----------------------------------------------------------------------------------|

----

|                                                                                                     |   |   3                  Months Ended September 30, 2005 |     |   1                  Month Ended August 1, 2004 |   |   2                  Months Ended September 30, 2004 |   |   9                  Months Ended September 30, 2005 |     |   7                  Months Ended August 1, 2004 |   |   2                  Months Ended September 30, 2004 |   | August                  2, 2004 (Inception of Successor Company) to September 30,                  2005 |     |
|----------------------------------------------------------------------------------------------------------|--------|----------------------------------------------------------------|----------|-----------------------------------------------------------|--------|----------------------------------------------------------------|--------|----------------------------------------------------------------|----------|------------------------------------------------------------|--------|----------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------|----------|
| Net                  income (loss) as reported                                                           |   | $                                                              | (149,432 | )                                                         | $      | 487,428                                                        |   | $                                                              | (215,503 | )                                                          | $      | (657,692                                                       | )      | $                                                                                                       | 394,598  |   | $ | (215,503 | ) | $ | (1,035,383 | ) |
| Stock-based                  compensation expense includedin                  reported net income (loss) |   |                                                           | (18,018  | )                                                         |   | —                                                        |   |                                                           | 78,367   |                                                       |   | 103,326                                                        |   |                                                                                                    | —  |   |   | 78,367 |   |   | 283,777 |   |
| Stock-based                  compensation                                                                |   |                                                           | 18,018   |                                                      |   | (19,107                                                        | )      |                                                           | (78,367  | )                                                          |   | (103,326                                                       | )      |                                                                                                    | (146,961 | ) |   | (78,367 | ) |   | (283,777 | ) |
| Pro                  forma net income (loss)                                                             |   | $                                                              | (149,432 | )                                                         | $      | 468,321                                                        |   | $                                                              | (215,503 | )                                                          | $      | (657,692                                                       | )      | $                                                                                                       | 247,637  |   | $ | (215,503 | ) | $ | (1,035,383 | ) |
| As                  reported income (loss) per share                                                     |   | $                                                              | (0.00    | )                                                         | $      | 0.02                                                           |   | $                                                              | (0.01    | )                                                          | $      | (0.02                                                          | )      | $                                                                                                       | 0.04     |   | $ | (0.01 | ) |   |   |   |
| Pro                  forma income (loss) per share                                                       |   | $                                                              | (0.00    | )                                                         | $      | 0.02                                                           |   | $                                                              | (0.01    | )                                                          | $      | (0.02                                                          | )      | $                                                                                                       | 0.03     |   | $ | (0.01 | ) |   |   |   |
|                                                                                                     |   |                                                           |     |                                                      |   |                                                           |   |                                                           |     |                                                       |   |                                                           |   |                                                                                                    |     |   |   |   |   |   |   |   |

|                             |   |                               |    |                               |   |
|----------------------------------|--------|------------------------------------|---------|------------------------------------|--------|
|                             |   | September                  30,2005 |    | December                  31, 2004 |   |
| Raw                  materials   |   | $                                  | 61,689  |                               | $      | 98,346 |   |
| Work                  in process |   |                               | — |                               |   | 4,832 |   |
| Finished                  goods  |   |                               | 84,930  |                               |   | 45,991 |   |
| Totals                           |   | $                                  | 146,619 |                               | $      | 149,169 |   |
|                             |   |                               |    |                               |   |   |   |

----

| **3.  ** | **Subsequent                  Events** |
|--------------------|----------------------------------------|

**Item        2.**
**        Management’s Discussion and Analysis or Plan of Operation**

**Safe        Harbor Statement Under the Private Securities Litigation Reform Act of        1995**

**Business**

----

**Plan        of Operation**

----

**Results        of Operations**

***For        the Three Months ended September 30, 2005***

***For        the Nine Months ended September 30, 2005***

----

**Item        3.**
**Controls        and Procedures**

|              |                                                                                             |
|-------------------|--------------------------------------------------------------------------------------------------|
| **PART II**  | **OTHER                  INFORMATION**                                                      |
|              |                                                                                             |
| **Item 1.**  | **Legal                  Proceedings**                                                      |
|              |                                                                                             |
|              | None                                                                                        |
|              |                                                                                             |
| **Item 2.**  | **Unregistered Sales of Securities                  and                  Use of Proceeds**  |
|              |                                                                                             |
|              | None                                                                                        |
|              |                                                                                             |
| **Item 3.**  | **Defaults Upon Senior                  Securities**                                        |
|              |                                                                                             |
|              | None                                                                                        |
|              |                                                                                             |
| **Item 4.**  | **Submission of Matters to                  a Vote of                  Security Holders**   |
|              |                                                                                             |
|              | None                                                                                        |

----

|              |                                                                                                                                                                                           |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| **Item 5.**  | **Other                  Information**                                                                                                                                                    |
|              |                                                                                                                                                                                           |
|              | None                                                                                                                                                                                      |
|              |                                                                                                                                                                                           |
| **Item 6.**  | **Exhibits**                                                                                                                                                                              |
|              |                                                                                                                                                                                           |
| Exhibit 31   | Certification                    of Chief Executive Officer and Chief Financial                    Officer pursuant to Section 302 of the Sarbanes-Oxley Act of                    2002.  |
|              |                                                                                                                                                                                           |
| Exhibit 32   | Certification                    of Chief Executive Officer and Chief Financial                    Officer pursuant to Section 906 of the Sarbanes-Oxley Act of                    2002.  |

----

**SpectraScience,        Inc.**

**FORM        10-QSB**

**September        30, 2005**

**SIGNATURES**

|                                            |                                                                                                                                                                                                                          |                                  |
|-------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|
|                                            | **SpectraScience,                  Inc.**(Registrant)                                                                                                                                                                         |
|                                       |                                                                                                                                                                                                                     |                             |
| Date: **November                14, 2005** |                                                                                                                                                                                                                     | /s/ James                Hitchin |
|                                            | **James                Hitchin**                                                                                                                                                                                              |
|                                            | President,                  Chief Executive Officer and Chief                  Financial Officer(Principal executive officer, principal financial                  officer,and principal accounting                  officer) |

----